Company Overview
About Cleancard
Cleancard is a United States-based at-home cancer screening company — backed by Y Combinator (S23) with $846,000 in total funding from Mayo Clinic Platform, TQ Ventures, Urban Innovation Fund, Y Combinator, and the Creative Destruction Lab — developing a 30-minute at-home diagnostic platform that combines synthetic biology, machine learning, and computer vision to detect multiple cancer biomarkers from a single patient sample for prostate, bladder, and ovarian cancers. Founded by Luca Springer and Thomas Carroll (both Rhodes Scholars from Oxford), Cleancard targets the massive unmet need for accessible, affordable cancer screening outside of clinical settings — the 30-minute result time and home-based format enabling screening at the frequency and convenience required for early cancer detection programs.
Business Model & Competitive Advantage
Cleancard's at-home cancer screening technology addresses the access and adherence barriers that reduce the effectiveness of existing cancer screening programs: prostate-specific antigen (PSA) testing, bladder cancer urine cytology, and ovarian cancer CA-125 testing are all clinic-based procedures that require scheduling appointments, traveling to labs, and waiting days for results — friction that causes eligible patients to skip routine screening or delay follow-up after abnormal results. Cleancard's platform uses synthetic biology-engineered biosensors (designed to detect specific cancer biomarker proteins or genetic signatures in urine or blood samples) combined with computer vision analysis of the test result pattern (reading the quantitative biomarker level from the test strip or cartridge format) to deliver clinical-grade sensitivity and specificity in a consumer-facing format. The multiplexable format (detecting multiple cancer biomarkers from a single sample) enables panel testing that improves early detection probability compared to single-marker testing — a key advance over current single-analyte home tests. Mayo Clinic Platform's investment provides the clinical validation infrastructure and healthcare system distribution relationships that consumer diagnostic companies require for clinical adoption.
Competitive Landscape 2025–2026
In 2025, Cleancard competes in the at-home diagnostics, cancer screening, and consumer health testing market with Galleri (Illumina/GRAIL multi-cancer early detection liquid biopsy, $1.9B raised), Exact Sciences (NASDAQ: EXAS, Cologuard colorectal cancer screening, $1B revenue), and EarlySign (AI-based early cancer detection, $21M raised) for consumer and healthcare system early cancer detection platform adoption. Mayo Clinic Platform's partnership (Mayo Clinic is one of the world's most trusted healthcare institutions) provides clinical validation credibility critical for consumer cancer diagnostic adoption where clinical trust is paramount. Rhodes Scholar founding team backgrounds reflect the academic research rigor that translates synthetic biology biosensor research into manufacturable consumer diagnostic products. The 2025 strategy focuses on achieving clinical validation data for the prostate and bladder cancer panels, pursuing FDA 510(k) clearance for at-home use authorization, and building the telehealth follow-up pathway for patients with positive screening results.
Recent Activity
View all →Foreign Filing filed 2026-09-16
Foreign Filing filed 2026-09-15
Foreign Filing filed 2026-09-04
Foreign Filing filed 2026-09-03
Foreign Filing filed 2026-08-25
Foreign Filing filed 2026-08-25
Foreign Filing filed 2026-08-25
Foreign Filing filed 2026-08-25
Foreign Filing filed 2026-08-25
Foreign Filing filed 2026-08-25
Foreign Filing filed 2026-08-11
Key Differentiators
Emerging Innovator
Cleancard is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Epic Systems
Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale el
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Oracle Health
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve
Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan
Moderna
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép
Amgen
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic
Compare Cleancard with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Cleancard? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Cleancard Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Cleancard vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →